Crossref
Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease
European Journal of Cancer Supplements · 2004
DOI: 10.1016/j.ejcsup.2004.01.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer Supplements, 2004. Verfasst von B. Leyland-Jones. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Leyland-Jones, B. (2004). Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease. European Journal of Cancer Supplements. https://doi.org/10.1016/j.ejcsup.2004.01.003
Vancouver
Leyland-Jones B. Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease. European Journal of Cancer Supplements. 2004. doi:10.1016/j.ejcsup.2004.01.003
BibTeX
@article{LeylandJones2004,
author = {Leyland-Jones, B.},
title = {Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease},
journal = {European Journal of Cancer Supplements},
year = {2004},
doi = {10.1016/j.ejcsup.2004.01.003}
}
EUVIMED